UvA Ventures Holding

What UvA Ventures Holding does

UvA Ventures Holding BV is the technology transfer and venture holding entity of the University of Amsterdam, established in 1992 as a wholly owned subsidiary (Besloten Vennootschap) to maintain a strict legal separation between publicly funded research and private commercialization activities. The company enables scientific innovation originating from the University of Amsterdam to reach the market by founding and acquiring equity stakes in spin-off companies, and by managing spin-offs from affiliated institutions — Amsterdam UMC via Amsterdam UMC Ventures Holding and Hogeschool van Amsterdam via HvA Ventures Holding.

The portfolio is organized into three categories — contract research, services, and new ventures — spanning computer vision healthcare monitoring (Kepler Night Nurse), AI-driven immunotherapy patient selection (Ellogon EIDOS), remote geriatric rehabilitation (Hipper Platform), super-resolution microscopy (Confocal.nl RCM2), CO2-to-chemicals cyanobacteria processing (Photanol), CO2-based polymers (Plantics), RNA therapies for cardiomyopathies (Phlox Therapeutics), and online language learning (The Language Academy). The company also operates the Social Sciences & Humanities (SSH) Impact Fund launched in 2024, deploying €50K–€100K per spin-off.

UvA Ventures generates returns through temporary equity participation in portfolio companies, supported by governance, finance & control, management, and advisory services delivered in proportion to its ownership stake. Its GTM motion is enterprise relationship-driven: academics, portfolio companies, and external investors are engaged directly, with deal flow sourced through the IXA knowledge transfer office and channeled through ACE Incubator and Startup Village at Amsterdam Science Park. Key corporate partners include AkzoNobel, RENOLIT, Equinix, and Info Support; key financial partners include ROM InWest, ROM Utrecht Region, FIRST Fund (BioGeneration Ventures), and UHSF. Leadership consists of CEO Peter Krijnsen (director since August 2013) and Financial Director Rudi Rust (appointed September 2019).

Name

UvA Ventures Holding

Legal name

UvA Ventures Holding BV

Website

https://uvaventures.nl

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

UvA Ventures Holding BV is the wholly owned technology-transfer and venture-holding subsidiary of the University of Amsterdam, founded in 1992 to commercialize academic research by founding and investing in spin-off companies across contract research, services, and new ventures.

Ownership category

akta.pro rank

Product category

University Technology Transfer / Academic Venture Holding

NAICS

Management of Companies and Enterprises (55111), Other Financial Vehicles (525990), Professional, Scientific, and Technical Services (541)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282), Non-Operating Establishments (9995)

akta.pro industry

PRIMARYFSANAAAF

Corporate Venture Capital (CVC)

Financial & Insurance/Private Equity & Venture Capital/Venture Capital Firms

SECONDARYFSANAHAF

Corporate Strategic Partnership & Ecosystem Investment Arms

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

SECONDARYFSANAHAE

Joint Venture CVC / Consortium Funds (Multi-corporate)

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

Keywords

• University technology transfer
• Academic spin-off investment
• Venture holding services
• Research commercialization
• Knowledge valorization

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investment returns and equity stakes: UvA Ventures generates returns through equity participation in spin-off companies. Participation is temporary; exit timing depends on company developments. They also provide governance and management services to portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

UvA Ventures Holding BV commercializes scientific research and expertise from the University of Amsterdam by founding or participating in spin-off companies and providing governance, finance & control, management, and advisory services to those portfolio companies across contract research, services, and new ventures categories. It also manages dedicated investment vehicles including the SSH Impact Fund, and oversees holdings for affiliated institutions (Amsterdam UMC Ventures Holding and HvA Ventures Holding).

Product overview

UvA Ventures Holding is a university holding company (wholly owned subsidiary of the University of Amsterdam, established in 1992) that enables scientific innovation and expertise to reach the market. It does not sell a single unified product but manages a portfolio of spin-off companies across three categories: contract research, services, and new ventures. Key portfolio products include Kepler Night Nurse (AI-powered computer vision for elderly care monitoring), the Hipper Platform (digital rehabilitation monitoring), Ellogon's EIDOSTM (AI for immunotherapy selection), Confocal.nl's RCM2 microscope (super-resolution imaging), and The Language Academy (online language learning). UvA Ventures also manages the SSH Impact Fund for social sciences and humanities spin-offs.

Differentiator

Problem solved

Functional benefit

Brands

• SSH Impact Fund: Social Sciences & Humanities Impact Fund launched by UvA Ventures Holding to capitalize on SSH research by supporting the development of academic spin-offs that address societal challenges.

Products and services

• SSH Impact Fund (Social Sciences & Humanities Impact Fund) A dedicated venture/loan fund managed by UvA Ventures Holding that supports academic spin-offs in the Social Sciences & Humanities by providing 50,000–100,000 EUR per spin-off via business or convertible loans (maximum eight-year tenor), targeting UvA-origin research that addresses societal challenges. Intended beneficiaries are UvA-affiliated academic founders creating for-impact companies from SSH research.

Quantifiable outcome

• Supports commercialization of innovations from University of Amsterdam
• +1 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Partnerships

Eleven partnerships are on record, tiered core, major and exit/acquisition.

• IXA-UvAcoreStrategic or Co-development PartnerKnowledge Transfer Office of University of Amsterdam supporting researchers in valorization, patent applications, subsidy advice, and complex collaboration arrangements.
• ACE IncubatorcoreStrategic or Co-development PartnerAmsterdam Center of Entrepreneurship provides incubation programs for startup founders with skills training for early-stage company development. Ranked #1 in Netherlands.
• Hubrecht InstitutemajorStrategic or Co-development PartnerResearch institute supporting Phlox Therapeutics through public-private partnership, deepening scientific understanding of cardiomyopathies.
• AkzoNobel Specialty ChemicalsmajorStrategic or Co-development PartnerStrategic partner hosting Photanol's demonstration plant at their Delfzijl site for industrial-scale chemical production from CO2.
• RENOLIT SEmajorStrategic or Co-development PartnerGlobal polymer products manufacturer partnering with Photanol to develop circular polymers using CO2-absorbed materials for healthcare applications.
• EquinixcoreStrategic or Co-development PartnerData center company sponsoring Startup Village until 2025, providing marketing support and organizing events for startups at Amsterdam Science Park.
• Info SupportcoreStrategic or Co-development PartnerIT solutions provider running Innovation Lab at Startup Village, supporting startups with workshops on AI and other technologies.
• Health~HollandmajorStrategic or Co-development PartnerDutch health research funding body supporting public-private partnerships in healthcare innovation including Phlox Therapeutics.
• Amsterdam UMC Ventures HoldingcoreOthersEarly-stage investor in academic spin-offs from Amsterdam UMC, working closely with academics and entrepreneurs at earliest company formation stages.
• HvA Ventures HoldingcoreOthersHolding company for spin-offs from Hogeschool van Amsterdam (University of Applied Sciences), similar structure to UvA Ventures.
• Prowiseexit/acquisitionOthersAcquired Oefenweb (Rekentuin, Taalzee, Words&Birds) - adaptive educational software company originally co-founded by UvA Ventures.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• BioGeneration Ventures (BGV): Dutch life sciences venture capital firm managing the FIRST Fund; a frequent co-investor with UvA Ventures in life sciences spin-offs (e.g., Phlox Therapeutics) with similar early-stage Dutch academic focus.
• Invest-NL: Dutch national investment institution focused on sustainability and impact investments; broader mandate than UvA Ventures but overlapping in funding innovative Dutch ventures including university spin-offs.
• Cambridge Enterprise: University of Cambridge's commercialization arm, providing equity investment and incubation to Cambridge spin-offs; same academic spin-out model with longer track record and larger portfolio.
• Oxford University Innovation: Oxford University's technology transfer and spin-out company; comparable university venture holding model but at materially larger scale, with broader portfolio and global investor network.

Direct peers

• Erasmus MC Holdings: Erasmus University Rotterdam's medical center holding vehicle; comparable academic medical spin-off holding with overlapping life sciences/healthcare focus and similar governance structure.
• Amsterdam UMC Ventures Holding: Sister holding entity managing Amsterdam UMC (academic medical center) spin-offs; structurally identical model (university-affiliated holding, equity stakes, management services) and explicitly coordinated with UvA Ventures.
• TU Delft Holding / Delft Enterprises: TU Delft's technology transfer and holding vehicle for spin-offs in deep tech, robotics, and engineering; same university venture holding model applied to a different Dutch research institution.
• HvA Ventures Holding: Holding company for spin-offs from Hogeschool van Amsterdam (University of Applied Sciences); same legal/governance structure as UvA Ventures and managed by the same team, making it a direct operational peer.
• Wageningen University & Research (WUR) Holding: Wageningen's spin-off holding focused on agritech, food, and sustainability spin-offs; analogous Dutch university holding model with comparable equity, governance, and valorization mandate.

Emerging players

• ROM InWest: Regional development company for North-Holland providing capital to healthcare, food, and energy transition ventures; a key co-investor alongside UvA Ventures in Kepler Vision, Ellogon, and SolarFoil.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/uva---amc-ventures---hva-holding-bv

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UvA Ventures Holding